Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-announced-first-rheumatoid-arthritis-patient-dosed-in-phase--clinical-study-of-lnk01001-302019129.html
https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-completes-series-c2-financing-round-with-total-c-round-funding-of-322-million-rmb-301933690.html
https://www.fiercebiotech.com/biotech/lynk-brushing-eqrx-rejection-hits-main-goal-wrap-clean-sweep-phase-2-jak-trials
https://www.fiercebiotech.com/biotech/after-eqrx-partnership-falls-apart-lynks-mid-stage-eczema-trial-hits-main-goals
https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-announced-positive-topline-data-from-phase-ii-clinical-trial-of-lnk01001-in-the-treatment-of-atopic-dermatitis-301895890.html
https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-announces-first-atopic-dermatitis-patient-dosed-with-lnk01004-in-phase-ib-clinical-study-301882254.html
https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-completes-200-million-rmb-series-c1-financing-to-accelerate-clinical-development-of-core-products-301837939.html
https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-announces-first-cohort-of-psoriatic-patients-dosed-with-lnk01004-in-phase-ib-clinical-study-301834096.html
https://www.clinicaltrialsarena.com/news/lynk-first-cohort-psoriasis-therapy/
https://www.prnewswire.com/news-releases/lynk-pharmaceuticals-announces-positive-results-for-lnk01003-in-phase-i-trial-in-healthy-subjects-301788958.html